Our Products

In collaboration with King's College London, Avegen has developed a solution to support individuals with multiple sclerosis (MS) who experience fatigue. It establishes a key communication channel between patients and their healthcare providers, enhancing access to care and increased support for these patients.

Digestive health is an all-in-one digital health mobile solution that allows patients to manage their gut health on a daily basis. Digestive health was launched in January 2024 in partnership with digestive health experts, to target an unmet need in the market when it comes to supporting diarrhoea sufferers holistically to manage their condition. Working as a pocket companion for users' gut health needs, Digestive health allows users to take control of their symptom management and understand their condition better in their own personalised app through targeted features.

HealthMachine® was deployed in Bucks, Oxford and West Berkshire Integrated Care Board (BOB-ICB) to create a digital health product designed to reduce relapse in heart conditions and improve patient adherence to the cardiac rehab (CR) program. Avegen has collaborated with BOB-ICB to create a cardiac rehabilitation digital health product to serve both patients and clinicians in order to improve patient management and support across the care journey. The aim is to reduce relapse across heart conditions and improve patient adherence to the CR program delivered at the clinic.

Avegen created a mobile app that aims to improve outcomes for patients during their prostate cancer journey, specifically before and after robotic prostatectomy called Pro-Recover. We collaborated with a world leading urologist Professor Prasanna Sooriakumaran, to design a digital application that would empower patients before and after surgery to manage their journey and recovery.We worked closely with individuals with lived experience of prostate cancer whilst creating the app. Throughout the app development process, we actively sought user input by inviting them to review content and share their feedback. Their valuable insights played a crucial role in guaranteeing that this app remains patient-centered. Avegen developed this app in an 8 week time frame in summer 2023 and it is currently being used by patients from specific urology clinics in London.

Healthmachine™ created a solution designed to support people living with pulmonary arterial hypertension (PAH). It is live in eight countries across Europe, helping more than 5% of the total diagnosed PAH patient population manage their condition in the launched markets.

Avegen has developed a mobile app that aims to improve the mental health of people with long-term physical health conditions (LTCs) such as multiple sclerosis, IBD, Crohn's and psoriasis called Orbi. Based on extensive research out of King’s College London’s Health Psychology Section, Orbi builds on the existing solution COMPASS (a Class I certified medical device), supporting physical and mental wellbeing together.

Together for Her (TFH) is a digital care program that aims to empower expectant mothers with accurate information, personalised guidance, and a supportive community throughout their pregnancy journey. TFH offers holistic, evidence-based support that prioritises the physical, emotional, and mental well-being of expectant mothers, empowering women with knowledge, activating them towards healthy behaviours, and triggering know-how and demand for good quality of care (QOC). The TFH care program was launched in July 2020. It has since been installed more than 2 million times, reaching 1.5 million mothers in total (i.e., mothers who engaged with the program after installing the app and completed the first assessment).

Successful Treatment Of Paranoia (STOP) is a patient-facing digital solution that uses an app to deliver a course of therapy to patients experiencing paranoia. Working with King’s College London (KCL), we built STOP using HealthMachine™ to make life better for patients with debilitating mental health symptoms. STOP has received MHRA approval to undergo clinical investigation and is currently being trialled in a study at KCL.

Klick is a nurse-led, digital solution for patients living with HIV who attend Chelsea and Westminster Hospital Foundation Trust (CWFT) for outpatient care. Working with CWFT and a major pharmaceutical company, we built the Klick care pathway to integrate with CWFT’s outpatient services, using Healthmachine™. It supports people living with HIV to understand their health and changing needs. More than 6,000 patients currently use Klick.